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ABSTRACT 
 
 
Acute Coronary Syndrome is a chronic disease which requires immediate and 
long term treatment. Thus, there are many challenges in sustaining the continuity of 
the treatment especially when patients are discharged from hospital to primary care. 
Several factors that interrupt the sustainability and continuity of the treatment have 
been identified. One of the factors that cause disrupted treatment includes interruption 
in getting the medication. In Malaysia, there are limited local studies on the continuity 
of Clopidogrel treatment at the primary care. This study aims to find the frequency of 
interrupted refill of Clopidogrel in primary care and its implications. This was a 
retrospective study involving 115 ACS patients who were discharged from the 
hospital between January 1, 2014 and December 31, 2015 to the primary care. Out of 
115 patients, 75(65.2%) patients were male, 40(34.8%) patients were female with age 
ranging between 31 to 80 years old. The distribution of ethnicity includes all the major 
races in Malaysia. There were 54(47.0%) Malay patients, 39(33.9%) Indian patients 
and 22(19.1%) Chinese patients. It was found that most of the patients (N=89, 
77.39%) did not comply and had interrupted Clopidogrel refill prescriptions and only 
22.6% of patients (N= 26) complied and refilled their prescriptions monthly without 
fail. No variables are significantly associated to the interrupted refill. The implication 
of interrupted Clopidogrel refill was found to be associated with the increased risk of 
re-admission due to Myocardial infarction (OR 10.25; 95% CI 2.28 – 46.00; p<0.005). 
In a healthcare system that is being funded by the government, there should be no 
reasons for interrupted refill especially in chronic diseases. There is a need to identify 
best approaches to improve or optimize prescriptions filling after patients were 
discharged from hospital.  
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